Activity of cefotaxime and amikacin against 14,272 gram-negative bacteria from clinical samples in the period 1980 to 1985. 1988

D Dámaso, and M P Sánchez-Moreno, and L Martínez-Martínez, and E Mesa, and F Portero, and P Mendaza, and R M Daza
Clínica Puerta de Hierro, Servício de Microbiología, Madrid.

The sensitivity to cefotaxime and amikacin of 14,272 Gram-negative bacilli (Enterobacteriaceae and non-fermenting Gram-negative bacilli) isolated from clinical samples was studied during the period 1980 to 1985. The minimum inhibitory concentration (MIC) was determined by means of diffusion in agar. Strains were considered resistant to cefotaxime and amikacin if the MIC values were greater than 16 mg/L and greater than 8 mg/L, respectively. The MIC90 reached the critical value for cefotaxime in the case of Citrobacter spp., Escherichia coli, Klebsiella spp., Proteus mirabilis, Salmonella spp. and Shigella spp., and for amikacin in the case of Citrobacter spp., Enterobacter spp., E. coli, Klebsiella spp., P. mirabilis, Proteus vulgaris, Salmonella spp. and Serratia spp. Only Shigella spp. were sensitive to cefotaxime but not to amikacin, and only strains of Enterobacter spp. and Serratia spp. were sensitive to amikacin but not to cefotaxime.

UI MeSH Term Description Entries
D002439 Cefotaxime Semisynthetic broad-spectrum cephalosporin. Benaxima,Biosint,Cefotaxim,Cefotaxime Sodium,Cefradil,Cephotaxim,Claforan,Fotexina,HR-756,Kendrick,Klaforan,Primafen,Ru-24756,Taporin,HR 756,HR756,Ru 24756,Ru24756,Sodium, Cefotaxime
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D004755 Enterobacteriaceae A family of gram-negative, facultatively anaerobic, rod-shaped bacteria that do not form endospores. Its organisms are distributed worldwide with some being saprophytes and others being plant and animal parasites. Many species are of considerable economic importance due to their pathogenic effects on agriculture and livestock. Coliform Bacilli,Enterobacteria,Ewingella,Leclercia,Paracolobactrum,Sodalis
D000583 Amikacin A broad-spectrum antibiotic derived from KANAMYCIN. It is reno- and oto-toxic like the other aminoglycoside antibiotics. A.M.K,Amikacin Sulfate,Amikacina Medical,Amikacina Normon,Amikafur,Amikalem,Amikason's,Amikayect,Amikin,Amiklin,Amukin,BB-K 8,BB-K8,Biclin,Biklin,Gamikal,Kanbine,Oprad,Yectamid,BB K 8,BB K8,BBK 8,BBK8,Medical, Amikacina,Normon, Amikacina,Sulfate, Amikacin
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

D Dámaso, and M P Sánchez-Moreno, and L Martínez-Martínez, and E Mesa, and F Portero, and P Mendaza, and R M Daza
July 1983, Revista medica de Chile,
D Dámaso, and M P Sánchez-Moreno, and L Martínez-Martínez, and E Mesa, and F Portero, and P Mendaza, and R M Daza
June 1986, Antimicrobial agents and chemotherapy,
D Dámaso, and M P Sánchez-Moreno, and L Martínez-Martínez, and E Mesa, and F Portero, and P Mendaza, and R M Daza
March 1981, The Japanese journal of antibiotics,
D Dámaso, and M P Sánchez-Moreno, and L Martínez-Martínez, and E Mesa, and F Portero, and P Mendaza, and R M Daza
January 1985, Giornale italiano di chemioterapia,
D Dámaso, and M P Sánchez-Moreno, and L Martínez-Martínez, and E Mesa, and F Portero, and P Mendaza, and R M Daza
January 1982, Reviews of infectious diseases,
D Dámaso, and M P Sánchez-Moreno, and L Martínez-Martínez, and E Mesa, and F Portero, and P Mendaza, and R M Daza
September 1977, Antimicrobial agents and chemotherapy,
D Dámaso, and M P Sánchez-Moreno, and L Martínez-Martínez, and E Mesa, and F Portero, and P Mendaza, and R M Daza
July 1989, Journal of chemotherapy (Florence, Italy),
D Dámaso, and M P Sánchez-Moreno, and L Martínez-Martínez, and E Mesa, and F Portero, and P Mendaza, and R M Daza
April 1989, Antimicrobial agents and chemotherapy,
D Dámaso, and M P Sánchez-Moreno, and L Martínez-Martínez, and E Mesa, and F Portero, and P Mendaza, and R M Daza
April 1988, Microbiologica,
D Dámaso, and M P Sánchez-Moreno, and L Martínez-Martínez, and E Mesa, and F Portero, and P Mendaza, and R M Daza
January 1990, Drugs under experimental and clinical research,
Copied contents to your clipboard!